Today, Saturday, November 10, 2018, Dr. Deepak Bhatt, principal investigator of the Evaluation of the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients With Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events With EPA – Intervention Trial) reported on encouraging results of the use of high-dose purified prescription level omega-3 fatty acids. His presentation took place at the annual American Heart Association meeting in Chicago. Click or tap here for a discussion of the REDUCE-IT trial results.
Nov 10 2018
Comments (0)Antiplatelet Therapy
No comments here.